Published in Nat Rev Neurol on May 25, 2010
Usefulness of data from magnetic resonance imaging to improve prediction of dementia: population based cohort study. BMJ (2015) 2.10
Predicting dementia risk in primary care: development and validation of the Dementia Risk Score using routinely collected data. BMC Med (2016) 2.05
Nontraditional risk factors combine to predict Alzheimer disease and dementia. Neurology (2011) 1.81
Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores. Neurology (2013) 1.44
FRAILTY: A Report from the 3(rd) Joint Workshop of IAGG/WHO/SFGG, Athens, January 2012. Can Geriatr J (2012) 1.04
Development and validation of a brief dementia screening indicator for primary care. Alzheimers Dement (2014) 1.02
Age-related deficit accumulation and the risk of late-life dementia. Alzheimers Res Ther (2014) 0.99
Cardiovascular disease risk models and longitudinal changes in cognition: a systematic review. PLoS One (2014) 0.93
Integrating health into cognitive aging: toward a preventive cognitive neuroscience of aging. J Gerontol B Psychol Sci Soc Sci (2011) 0.91
Understanding noninferiority trials. Korean J Pediatr (2012) 0.91
Predicting risk of 2-year incident dementia using the CAMCOG total and subscale scores. Age Ageing (2013) 0.89
Cognitive Functions across the GNB3 C825T Polymorphism in an Elderly Italian Population. Neurol Res Int (2013) 0.87
Current Developments in Dementia Risk Prediction Modelling: An Updated Systematic Review. PLoS One (2015) 0.87
Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research. Age Ageing (2011) 0.87
Internet-based screening for dementia risk. PLoS One (2013) 0.81
Dementia: Risk prediction models in dementia prevention. Nat Rev Neurol (2015) 0.81
Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation. Schizophr Bull (2017) 0.78
Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men. Biomed Res Int (2015) 0.75
A Late Life Risk Index for Severe Cognitive Impairment in Mexico. J Alzheimers Dis (2016) 0.75
Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years. Alzheimers Res Ther (2017) 0.75
Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study. BMJ (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation (2007) 20.44
Current concepts in mild cognitive impairment. Arch Neurol (2001) 18.09
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA (2009) 7.29
Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem (2007) 5.23
Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol (2006) 4.54
Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology (2004) 3.94
Classification criteria for mild cognitive impairment: a population-based validation study. Neurology (2001) 3.92
Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand (2008) 3.65
Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch Neurol (2002) 3.17
Mild cognitive impairment: long-term course of four clinical subtypes. Neurology (2006) 2.93
Predicting risk of dementia in older adults: The late-life dementia risk index. Neurology (2009) 2.92
Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology (1994) 2.84
Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology (2002) 2.79
Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology (2007) 2.72
Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology (2005) 2.45
Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol (2009) 2.26
Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr (1994) 2.24
Apolipoprotein E and cognitive change in an elderly population. Ann Neurol (1996) 2.05
Within-person across-neuropsychological test variability and incident dementia. JAMA (2008) 1.98
The incidence of dementia in England and Wales: findings from the five identical sites of the MRC CFA Study. PLoS Med (2005) 1.86
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology (2008) 1.80
Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc (2008) 1.74
Predicting who will develop dementia in a cohort of Canadian seniors. Can J Neurol Sci (2000) 1.67
Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. BMJ (2003) 1.65
Multiple cognitive deficits during the transition to Alzheimer's disease. J Intern Med (2004) 1.59
Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br J Psychiatry (2003) 1.58
Attention and executive control predict Alzheimer disease in late life: results from the Berlin Aging Study (BASE). Am J Geriatr Psychiatry (2005) 1.57
Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. CMAJ (2004) 1.52
The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage (2005) 1.47
Revised criteria for mild cognitive impairment: validation within a longitudinal population study. Dement Geriatr Cogn Disord (2006) 1.42
Subclassifications for mild cognitive impairment: prevalence and predictive validity. Psychol Med (2003) 1.41
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology (2009) 1.30
Preclinical syndromes predict dementia: the Sydney older persons study. J Neurol Neurosurg Psychiatry (2001) 1.30
Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Dementia risk indices: A framework for identifying individuals with a high dementia risk. Alzheimers Dement (2010) 1.27
Cognitive deficits 3 to 6 years before dementia onset in a population sample: the Honolulu-Asia aging study. J Am Geriatr Soc (2005) 1.25
Operationalization of mild cognitive impairment: a graphical approach. PLoS Med (2007) 1.22
Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement Geriatr Cogn Disord (2005) 1.14
CSF Abeta42, tau and phosphorylated tau correlate with medial temporal lobe atrophy. J Alzheimers Dis (2008) 1.06
CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies. J Neurol Neurosurg Psychiatry (2009) 0.98
Mild cognitive impairment in the older population: Who is missed and does it matter? Int J Geriatr Psychiatry (2008) 0.96
Mild cognitive impairment: prevalence and predictive validity according to current approaches. Acta Neurol Scand (2003) 0.94
A vascular risk factor index in relation to mortality and incident dementia. Eur J Neurol (2006) 0.94
Does a reliable decline in Mini Mental State Examination total score predict dementia? Diagnostic accuracy of two reliable change indices. Dement Geriatr Cogn Disord (2009) 0.92
Predictive value of mild cognitive impairment for dementia. The influence of case definition and age. Dement Geriatr Cogn Disord (2009) 0.91
Combined memory and executive function tests can screen mild cognitive impairment and converters to dementia in a community: the Osaki-Tajiri project. Neuroepidemiology (2009) 0.90
Prediction of Alzheimer dementia with short neuropsychological instruments. J Neural Transm (Vienna) (2009) 0.87
Characteristics of elderly who develop Alzheimer's disease during the next two years-a neuropsychological study using CAMCOG. The Odense Study. Int J Geriatr Psychiatry (1999) 0.87
Biomarkers of mild cognitive impairment and Alzheimer's disease. Ann Acad Med Singapore (2008) 0.85
Lack of prognostic significance of SPECT abnormalities in non-demented elderly subjects with memory loss. Can J Neurol Sci (1999) 0.83
Predictors of clinical outcome in MCI. Med Sci Monit (2007) 0.81
Measuring cognitive change in older adults. Do reliable change indices of the SIDAM predict dementia? J Neurol (2007) 0.80
Screening for Alzheimer's dementia at age 78 with short psychometric instruments. Int Psychogeriatr (2009) 0.77
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Global prevalence of dementia: a Delphi consensus study. Lancet (2005) 23.30
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32
The cervical cancer epidemic that screening has prevented in the UK. Lancet (2004) 7.72
Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol (2006) 6.97
Age, neuropathology, and dementia. N Engl J Med (2009) 6.36
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
Incidence of Dementia over Three Decades in the Framingham Heart Study. N Engl J Med (2016) 5.55
Alzheimer's disease. Lancet (2011) 5.35
Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol (2008) 5.28
Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13
Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ (2009) 4.98
Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 4.63
Benzodiazepine use and risk of dementia: prospective population based study. BMJ (2012) 4.32
Epidemiology of Alzheimer disease. Nat Rev Neurol (2011) 4.13
Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry (2009) 3.97
Political drive to screen for pre-dementia: not evidence based and ignores the harms of diagnosis. BMJ (2013) 3.93
White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke (2006) 3.27
A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies. J Clin Epidemiol (2005) 3.04
Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. BMJ (2008) 3.03
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain (2009) 3.03
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol (2009) 2.94
Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc (2011) 2.88
A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol Biomarkers Prev (2007) 2.77
Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Hum Mol Genet (2007) 2.73
A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord (2005) 2.70
Exceptional longevity in men: modifiable factors associated with survival and function to age 90 years. Arch Intern Med (2008) 2.67
Cardiovascular disease and subsequent kidney disease. Arch Intern Med (2007) 2.65
Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain (2012) 2.64
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57
Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J Natl Cancer Inst (2009) 2.50
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study. BMJ (2012) 2.32
Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis (2005) 2.30
The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain (2010) 2.29
Analysis of longitudinal studies with death and drop-out: a case study. Stat Med (2004) 2.24
Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID Study. J Am Geriatr Soc (2003) 2.23
Inability to get up after falling, subsequent time on floor, and summoning help: prospective cohort study in people over 90. BMJ (2008) 2.23
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry (2013) 2.20
Migraine and mortality: a systematic review and meta-analysis. Cephalalgia (2011) 2.18
Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes (2004) 2.17
The natural history of treated Parkinson's disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry (2011) 2.08
Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis. Cephalalgia (2011) 2.07
Migraine and obesity: epidemiology, mechanisms, and implications. Headache (2009) 2.05
Complications of endotracheal intubation in the critically ill. Intensive Care Med (2008) 2.04
Depressive symptoms and cognitive decline in elderly people. Longitudinal study. Br J Psychiatry (2002) 2.03
Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ (2008) 2.01
Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet (2011) 1.98
The burden of diseases on disability-free life expectancy in later life. J Gerontol A Biol Sci Med Sci (2007) 1.98
Attrition and bias in the MRC cognitive function and ageing study: an epidemiological investigation. BMC Public Health (2004) 1.97
What sleep characteristics predict cognitive decline in the elderly? Sleep Med (2012) 1.96
A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 1.94
Carotid sinus hypersensitivity in asymptomatic older persons: implications for diagnosis of syncope and falls. Arch Intern Med (2006) 1.94
Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis (2008) 1.92
A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res (Phila) (2010) 1.92
Geographic patterns in overall and specific cardiovascular disease incidence in apparently healthy men in the United States. Stroke (2007) 1.91
Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. Br J Psychiatry (2009) 1.91
Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study. Stroke (2010) 1.91
Trachoma survey methods: a literature review. Bull World Health Organ (2009) 1.90
Exposure to secondhand smoke and cognitive impairment in non-smokers: national cross sectional study with cotinine measurement. BMJ (2009) 1.89
Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol (2003) 1.87
The incidence of dementia in England and Wales: findings from the five identical sites of the MRC CFA Study. PLoS Med (2005) 1.86
Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache (2006) 1.86
Physical activity and risk of stroke in women. Stroke (2010) 1.85
Educational differences in the dynamics of disability incidence, recovery and mortality: Findings from the MRC Cognitive Function and Ageing Study (MRC CFAS). Int J Epidemiol (2007) 1.82
A global model for effective use and evaluation of e-learning in health. Telemed J E Health (2013) 1.82
Interobserver agreement in the classification of stroke in the Women's Health Study. Stroke (2003) 1.81
Relationship between blood pressure and depression in the elderly. The Three-City Study. J Hypertens (2008) 1.79
Multiple biological pathways link cognitive lifestyle to protection from dementia. Biol Psychiatry (2011) 1.79
Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet (2012) 1.79
Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc (2008) 1.74
DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet (2006) 1.73
Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med (2009) 1.72
Life course trajectories of systolic blood pressure using longitudinal data from eight UK cohorts. PLoS Med (2011) 1.71
The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis. Am J Med (2007) 1.70
What do we mean by Alzheimer's disease? BMJ (2010) 1.69
Education, the brain and dementia: neuroprotection or compensation? Brain (2010) 1.68
Cohort profile: the Medical Research Council Cognitive Function and Ageing Study (CFAS). Int J Epidemiol (2006) 1.61
Age-related cataract in a randomized trial of vitamins E and C in men. Arch Ophthalmol (2010) 1.60
The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension (2004) 1.59
Chronic disease in men with newly diagnosed cancer: a nested case-control study. Am J Epidemiol (2010) 1.58
Migraine, weight gain and the risk of becoming overweight and obese: a prospective cohort study. Cephalalgia (2012) 1.55
Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications. Anesthesiology (2015) 1.54
Prevalence and causes of blindness and low vision in southern Sudan. PLoS Med (2006) 1.54
Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort (CC75C) study. J Alzheimers Dis (2009) 1.53